I
InSteps provides an in-silico platform for simulating acute ischemic stroke treatment, specifically focusing on thrombectomy devices. This technology allows for the virtual testing of stent designs against diverse patient anatomies and clot compositions. The platform accelerates medical device development and optimizes clinical trial planning by generating predictive patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- InSteps provides an in-silico platform for simulating stroke treatment, enabling the virtual testing of thrombectomy devices against diverse patient anatomies and clot compositions. This technology accelerates medical device development by offering robust predictive modeling for stent performance and risk assessment. The platform supports regulatory submissions by generating evidence that optimizes clinical trial design and speeds time to market for novel neuro-interventional therapies.